Top

Published in:

01-01-2012 | Editorial

The mesh debate

Authors: Peter L. Dwyer, Paul Riss

Published in: International Urogynecology Journal | Issue 1/2012

Excerpt

The U.S. Food and Drug Administration (FDA) published a second warning to medical practitioners and patients on “Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse” in July 2011. Following this, on the advice of legal advisors the research and ethics committee of one of our hospitals (P.L.D) recommended that no further synthetic mesh be used for any incontinence or prolapse surgery. This recommendation was a case of “throwing the baby out with the bath water” and was not ratified following further discussion. However, it is an indication of the perfect storm referred to by Brubaker and Shull in this issue of the International Urogynecology Journal [1]. In order to give a range of opinions we are also publishing in this issue the views of other well-known gynaecologists on the usage of synthetic grafts [2, 3]. …

Brubaker L, Shull B (2011) A perfect storm. Int Urogynecol J. doi:10.1007/s00192-011-1596-8

Murphy M, Holzberg A, van Raalte H, Kohli N, Goldman HB, Lucente V, on behalf of the Pelvic Surgeons Network (2011) Time to rethink: an evidence-based response from pelvic surgeons to the FDA Safety Communication “Update on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse”. Int Urogynecol J. doi:10.1007/s00192-011-1581-2

Haylen BT, Sand PK, Swift SE, Maher C, Moran PA, Freeman RM (2011) Transvaginal placement of surgical mesh for pelvic organ prolapse: more FDA concerns—positive reactions are possible. Int Urogynecol J. doi:10.1007/s00192-011-1580-3

Moir JC (1968) The gauze-hammock operation (a modified Aldridge sling procedure). J Obstet Gynaecol Br Commonw 75(1):1–9PubMedCrossRef

Julian TM (1996) Efficacy of Marlex mesh in the repair of severe, recurrent vaginal prolapse of the anterior midvaginal wall. Am J Obstet Gynecol 175:1472–1475PubMedCrossRef

Dwyer PL, O’Reilly BA (2004) Transvaginal repair of anterior and posterior compartment prolapse with Atrium polypropylene mesh. Br J Obstet Gynaecol 111(8):831–836CrossRef

Abed H, Rahn DD, Lowenstein L, Balk EM, Clemons JL, Rogers RG (2011) Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review. Int Urogynecol J 22(7):789–98PubMedCrossRef

Jha S, Moran P (2011) The UK national prolapse survey: 5 years on. Int Urogynecol J 22(5):517–28PubMedCrossRef

Vanspauwen R, Seman E, Dwyer P (2010) Survey of current management of prolapse in Australia and New Zealand. Aust N Z J Obstet Gynaecol 50(3):262–7PubMedCrossRef

10.

FDA Safety Communications: UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse. (2011) http://www.fda.gov/MedicalDevices/Safety/AlertandNotices/ucm262435.htm

Title: The mesh debate
Authors: Peter L. Dwyer
Paul Riss
Publication date: 01-01-2012
Publisher: Springer-Verlag
Published in: International Urogynecology Journal / Issue 1/2012
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-011-1597-7

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The mesh debate

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2012

Reflections on my career as a urogynecologist

Transvaginal placement of surgical mesh for pelvic organ prolapse: more FDA concerns—positive reactions are possible

Management of recurrent vault prolapse

A perfect storm

TVT SECUR™ System: Final results of a prospective, observational, multicentric study

Single-incision vaginal approach to treat cystocele and vault prolapse with an anterior wall mesh anchored apically to the sacrospinous ligaments